Trial Profile
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2019
Price :
$35
*
At a glance
- Drugs Baclofen (Primary) ; Baclofen (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Sponsors IMPAX Laboratories
- 11 Nov 2014 New trial record